独家观察！华北多晴少雨利于小麦收割 东北部分地区需防渍涝

华北多晴少雨利于小麦收割 东北部分地区需防渍涝

（北京，2024年6月18日） 根据中央气象台发布的全国农业气象周报（2024年06月10日），未来10天，全国大部分地区以晴好天气为主，利于农业生产管理。

华北地区：预计未来10天，华北地区多晴少雨，气温偏高，部分地区有高温天气。华北中南部冬小麦收获接近尾声，晴好天气利于机收和晾晒。但需注意防范高温天气引发田间作业人员中暑。

黄淮地区：预计未来10天，黄淮地区多晴少雨，气温偏高，部分地区有高温天气。安徽、河南、河北南部等地部分地区土壤缺墒将持续或加剧，需注意防旱保苗。

东北地区：预计未来10天，东北地区大部气温接近常年同期，多阵性降水，黑龙江中东部、吉林及辽宁中部部分地区降水量有50~80毫米。总体利于玉米、大豆等旱地作物生长。但黑龙江东南部部分低洼农田土壤将持续过湿，渍涝害发生风险较高，需注意排水排涝。

西北地区：预计未来10天，西北地区多晴好天气，气温偏高，部分地区有高温天气。利于春玉米、春小麦等作物生长。

西南地区：预计未来10天，西南地区多阵性雷雨，川西、陕南、贵州东部等地部分地区有暴雨。降水有利于改善土壤墒情，对水稻、玉米等作物生长有利，但需注意防范雷雨大风、冰雹等强对流天气。

江南地区：预计未来10天，江南地区多阵性雷雨，部分地区有暴雨。降水有利于改善土壤墒情，对水稻、茶叶等作物生长有利，但需注意防范雷雨大风、冰雹等强对流天气。

华南地区：预计未来10天，华南地区多阵性雷雨，部分地区有暴雨。降水有利于改善土壤墒情，对水稻、甘蔗等作物生长有利，但需注意防范雷雨大风、冰雹等强对流天气。

总体来看，未来10天，全国大部分地区以晴好天气为主，利于冬小麦收获、夏播作物出苗及生长。但部分地区需注意防范高温、雷雨大风、冰雹、渍涝等灾害性天气对农业生产的不利影响。

（记者：Bard）

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.